Clinical performance evaluation of a rapid, low throughput test for KRAS, BRAF and EGFR mutation analysis

被引：0
|
作者：
Muriira, A. G. [1 ]
Mukadam, R. [1 ]
机构：
[1] Pathologists Lancet Kenya, Nairobi, Kenya
来源：
CLINICA CHIMICA ACTA | 2022年 / 530卷
关键词：
D O I：
10.1016/j.cca.2022.04.868
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
W113
引用
收藏
页码：S332 / S333
页数：2
相关论文
共 50 条
  • [21] Mutation analysis of PIK3CA, KRAS, BRAF and Corresponding EGFR status in head and neck squamous cell carcinoma
    Suda, Toshihito
    Hama, Takanori
    Okano, Susumu
    Seino, Youichi
    Yuza, Yuki
    Kato, Takakuni
    Moriyama, Hiroshi
    [J]. CANCER RESEARCH, 2011, 71
  • [22] DEVELOPMENT OF MULTIPLEX GENOTYPE TEST ON KRAS, EGFR AND BRAF TOWARD TARGETED THERAPY OF ANTICANCER DRUG
    Jung, Hye-Eun
    Cha, Eun-Young
    Kim, Eun-Young
    Shin, Jae-Gook
    Kim, Eun Koung
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S68 - S68
  • [23] Mutational Analysis of EGFR, KRAS and BRAF in Advanced Cholangiocarcinoma and Association with Clinical Outcomes - An Interim Report of a Phase II Trial
    Sohal, D.
    Teitelbaum, U.
    Uehara, T.
    Mykulowycz, K.
    Watt, C. D.
    Damjanov, N.
    Giantonio, B.
    Carberry, M.
    Wissel, P.
    Jacobs-Small, M.
    O'Dwyer, P.
    Sun, W.
    Sepulveda, A. R.
    Sun, W.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 697 - 697
  • [24] Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing
    Borras, Emma
    Jurado, Ismael
    Hernan, Imma
    Jose Gamundi, Maria
    Dias, Miguel
    Marti, Isabel
    Mane, Begona
    Arcusa, Angels
    Agundez, Jose A. G.
    Blanca, Miguel
    Carballo, Miguel
    [J]. BMC CANCER, 2011, 11
  • [25] Lung Adenocarcinoma EGFR, KRAS and BRAF Mutational Analysis, Histologic Correlation and Longitudinal Review
    Wachsmann, M. B.
    Glass, C.
    Butt, Y. M.
    Yan, S.
    Torrealba, J.
    Gokaslan, T.
    Sarode, V.
    Gerber, D.
    Dowell, J.
    Hughes, R.
    Kernstine, K.
    Abu-Hijleh, M.
    Chiu, H.
    Oliver, D.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1006 - 1006
  • [26] Analysis of KRAS, BRAF, and EGFR mutational status in respiratory epithelial adenomatoid hamartoma (REAH)
    Guimaraes, Leticia Martins
    Vieira, Tamara da Silva
    De Marco, Luiz Armando
    Thompson, Lester D. R.
    Gomes, Carolina Cavalieri
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2023, 52 (06) : 548 - 553
  • [27] Mutation in EGFR, HER2, KRAS and BRAF in NSCLC: Prevalences and correlations with clinical outcomes in patients treated with carboplatin and paclitaxel with or without erlotinib
    Eberhard, D
    Johnson, B
    Goddard, A
    Herbst, R
    Janne, P
    Johnson, D
    Klein, P
    Ostland, M
    Seshagiri, S
    Hillan, K
    [J]. LUNG CANCER, 2005, 49 : S62 - S62
  • [28] A multistep model for ovarian tumorigenesis:: the value of mutation analysis in the KRAS and BRAF genes
    Russell, SEH
    McCluggage, WG
    [J]. JOURNAL OF PATHOLOGY, 2004, 203 (02): : 617 - 619
  • [29] Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas
    Knobbe, CB
    Reifenberger, J
    Reifenberger, G
    [J]. ACTA NEUROPATHOLOGICA, 2004, 108 (06) : 467 - 470
  • [30] Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas
    Christiane B. Knobbe
    Julia Reifenberger
    Guido Reifenberger
    [J]. Acta Neuropathologica, 2004, 108 : 467 - 470
12345